Skip to main content
. Author manuscript; available in PMC: 2013 Oct 25.
Published in final edited form as: J Clin Exp Oncol. 2012 Aug 28;1(2):10.4172/2324-9110.1000102. doi: 10.4172/2324-9110.1000102

Figure 2. Nav1.8 immunohistochemical analysis of human prostate cancer cell lines.

Figure 2

DRG from rat tissue was used as a positive control for Nav1.8. Negative control (top panels) represents neutralization of Nav1.8 antibody with Nav1.8 peptide.